📰 Jeff Coller News
Jeff Coller News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jeff Coller. Real-time updates on events, politics, business and more.
May 16, 2024
The center, anchored in the Institute for NanoBioTechnology, will speed the cycle of RNA innovation in pursuit of advanced therapies
April 26, 2023
Genetic conditions like Dravet syndrome are hard to tackle with traditional gene therapy. But new approaches are in the works.
February 28, 2023
/PRNewswire/ -- Tevard Biosciences, Inc., the pioneer of tRNA-based therapies for severe genetic diseases, today announced a four-year global research...
August 3, 2022
/PRNewswire/ -- Tevard Biosciences, the pioneer of tRNA-based therapies for severe genetic diseases, today announced the appointment of leading tRNA scientist...
March 31, 2022
/PRNewswire/ -- Tevard Biosciences, the pioneer of tRNA-based treatments for severe genetic diseases, today announced an agreement to exclusively license "mRNA...
March 9, 2022
/PRNewswire/ -- Tevard Biosciences, the pioneer of tRNA-based treatments for severe genetic diseases, today announced the appointment of Paul Schimmel, Ph.D.,...
March 9, 2022
/PRNewswire/ -- Tevard Biosciences, the pioneer of tRNA-based treatments for severe genetic diseases, today announced the appointment of Paul Schimmel, Ph.D.,...
March 16, 2021
Molecular biologist Jeff Coller joins Johns Hopkins As a Bloomberg Distinguished Professor, he will hold appointments in the Krieger School of Arts and Sciences and the School of Medicine By Saralyn Cruickshank / Published March 16, 2021 It was during a research semester abroad in Stockholm, home of the Nobel Prize, that molecular biologist Jeff Coller discovered "scientist" was a viable career path for him, and it was a discovery that he calls magical....